• Return to Headlines

Incyte Up 27.6% Since SmarTrend Uptrend Call (INCY)

By David Diaz

SmarTrend identified an Uptrend for Incyte (NASDAQ:INCY) on January 9th, 2017 at $116.36. In approximately 2 months, Incyte has returned 27.64% as of today's recent price of $148.52.

In the past 52 weeks, shares of Incyte have traded between a low of $11.76 and a high of $153.15 and are now at $148.52, which is 1,163% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.9%.

Incyte Corporation is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. The Company has drug discovery programs underway focused on the identification of new small molecule drugs for cancer and inflammation.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Incyte shares.

Log in and add Incyte (INCY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights Incyte

Ticker(s): INCY